Page 65 - EMF von Stromtechnologien
P. 65
EMF von Stromtechnologien
One hundred five (105) new ELF-EMF papers (including two static field papers) that report on neuro-
logical effects of ELF-EMF published between 2007 and early 2014 are profiled. Of these, 95 (90%) show effects and 10 (10%) show no effect (...)
Sufficient evidence exists from epidemiological studies of an increased risk from exposure to EMF (power frequency ELF-EMF magnetic fields) and cannot be attributed to chance, bias or confounding. Therefore, according to the rules of IARC such exposures can be classified as a Group 1 carcinogen (Known Carcinogen) (...)
There is sufficient evidence to conclude that long-term relatively high ELF MF exposure can result in a decrease in melatonin production, which may increase risk for breast cancer (...)
There is strong epidemiologic evidence that exposure to ELF MF is a risk factor for AD [Alzheimer]. (...) There is considerable in vitro and animal evidence that melatonin protects against AD. Therefore it is certainly possible that low levels of melatonin production are associated with an increase in the risk of AD“.
Im Update von 2022 werden aktualisierte Zahlen für genotoxische Effekte angegeben (von total 311 Studien berichten 91% Effekte), ebenso für neurologische Effekte (von total 307 Studien berichten 84% Effekte).
In den späteren Kapiteln des vorliegenden Fachliteraturmonitorings wird auf Differenzen zwischen Be- wertungen des BioInitiative Reports und weniger alarmistischen Einschätzung eingegangen.
4.2.7 ARIMMORA
Das EU-Projekt ARIMMORA (“Advanced Research on Interaction Mechanisms of electroMagnetic ex- posures with Organisms for Risk Assessment”) hatte zum Ziel, mögliche biologische Mechanismen zu untersuchen, die den empirisch festgestellten Zusammenhang zwischen Kinderleukämie und Exposi- tion gegenüber Magnetfeldern erklären könnten. Zum Abschluss des Projektes wurde eine Risikoab- schätzung nach der Methode der IARC durchgeführt (Schuz et al., 2016). Das 22-köpfige Studienkon- sortium kam zu folgenden Schlussfolgerungen:
„...there is limited evidence of carcinogenicity in humans and inadequate evidence of carcinogenicity in experimental animals, with only weak supporting evidence from mechanistic studies. New exposure data from ARIMMORA confirmed that if the association is nevertheless causal, up to 2% of childhood leukemias in Europe, as previously estimated, may be attributable to ELF-MF. In summary, ARIMMORA concludes that the relationship between ELF-MF and childhood leukemia remains con- sistent with possible carcinogenicity in humans. While this scientific uncertainty is dissatisfactory for science and public health, new mechanistic insight from ARIMMORA experiments points to future re- search that could provide a step-change in future assessments.”
4.2.8 Ausgewählte nationale Reports
4.2.8.1 Deutschland (SSK)
Die deutsche Strahlenschutzkommission (SSK) veröffentlicht regelmässig Bewertungen der wissen- schaftlichen Literatur. Über den möglichen Zusammenhang zwischen NF-EMF und Krebs schreibt die (SSK, 2011), p. 49 und p. 52:
„Epidemiological studies offer incomplete evidence for a link between exposure to ELF magnetic fields and the risk of developing childhood leukaemia, but this is not supported by action models or other in- vestigative approaches. Overall, therefore, there is only weak evidence for a link with childhood leu-
65/204
C:\Users\jeberhar\Dropbox\2022 BFE Literaturmonitoring\Schlussbericht\20230228 _FAMES_FSM_Schlussbericht.docx
